Navigation Links
BioDelivery Sciences to Host Business Update Webcast and Conference Call on Tuesday, November 15, 2011 at 8:30 AM Eastern Time
Date:11/14/2011

e E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer.  The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).  BDSI's second pain product, BEMA Buprenorphine, is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation for the treatment of opioid dependence.  Additional product candidates are being developed utilizing the BEMA technology for conditions such as nausea/vomiting (BEMA Granisetron).  BDSI's headquarters is located in Raleigh, North Carolina.  For more information, visit www.bdsi.com.

BDSI® and BEMA® are registered trademarks of BioDelivery Sciences International, Inc.  ONSOLIS® is a registered trademark of Meda Pharmaceuticals, Inc.  BREAKYL is registered trademark of Meda Pharma GmbH & Co. KG.

Cautionary Note on Forward-Looking Statements

This press release, the presentation described herein and the statements of representatives and partners of BioDelivery Sciences International, Inc. (the "Company") related thereto contain, or may contain, among other things, certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, projections, expectations and intentions and other statements identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," or similar expressions.  These statements are based upon the current beliefs and expectations of the Company's
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
2. Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors
3. BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence
4. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
5. BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada
6. BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference
7. BioDelivery Sciences Provides Update on Status of Modified REMS Program for ONSOLIS
8. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
9. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
10. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
11. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced ... Investor Conference Call and webcast at 4:30 p.m., Eastern time, ... cover an update on Merrimack,s progress as well as ... release detailing the information to be discussed on the ... 10. Investors and the general public are invited to ...
(Date:8/3/2015)... PARK, N.J. , Aug. 3, 2015 ... and secondary endpoints in a phase III study (COMPOSE ... adult patients with chronic non-cancer pain. Naldemedine is an ... is the third Phase III trial in which naldemedine ... Study results showed that a 0.2 mg tablet of ...
(Date:8/3/2015)... LEXINGTON, Massachusetts , August 3, 2015 /PRNewswire/ ... SHPG ) announced today that it has ... held Foresight Biotherapeutics Inc. for $300 million. With ... FST-100 (topical ophthalmic drops combining 0.6% povidone iodine ... development for the treatment of infectious conjunctivitis, an ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6
... DUBLIN, Feb. 15, 2011 Warner Chilcott plc (Nasdaq: ... and full year 2010 financial results prior to the market opening ... issuing a press release, the Company will host a conference call ... AM (Eastern Time) to review the results. To participate in the ...
... Boston Scientific Corporation (NYSE: BSX ) ... treat peripheral chronic total occlusions (CTOs).  These acquisitions add ... devices for lower extremity peripheral artery disease.   ... 2010 from S.I. Therapies, Ltd., based in Israel.  The ...
Cached Medicine Technology:Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions 2Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions 3Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions 4
(Date:8/3/2015)... ... 03, 2015 , ... The art of preparing and cooking food comes naturally ... a young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that ... from My Persian Kitchen with the world. , Since Americans tend to be undereducated ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... the development of it’s new program “Designing Secure Healthcare Systems” This three-day, ... and technology leaders from healthcare organizations with access to the tactics, techniques and ...
(Date:8/3/2015)... Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... has emerged among U.S. emergency rooms in recent years, according to the American Dental ... the number of dental emergency visits went from 1.1 million in a single year ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has completed the ... acquisition includes all of IBAM NA’s cyclotron sites and research and development facilities. ... located business, as well as a large manufacturing hub in Noblesville, Indiana,” said Ken ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Constantin Vasilica, ... accompanied by tissue injury caused by diabetes after many years of suffering and using ... times, and he didn’t want to ask for extra time off or wait longer ...
Breaking Medicine News(10 mins):Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... Device "Rewires" Brain, Improves and Restores Balance, Normal Walking , ... ... on, "virtual reality" has a whole new meaning for people with ... walk normally again., , , , ,The GaitAid Virtual Walker, a ...
... that promises to one day allow drug delivery to be ... researchers at the University of California, San Diego School of ... primary cells. The work will be published in the May ... . , "RNAi has an unbelievable potential to manage cancer ...
... Dame warns TV networks that they will "cut the ... on Sunday.Dr. Alan Keyes to be available soon for interview ... 5 pro-lifers that have been held in jail without bond. ... The Following is Being Issued by Randall Terry, Founder of ...
... factors to help decide how aggressive therapy should be ... claim to have found a way to better customize ... that can help predict how long men could survive ... from the Duke Comprehensive Cancer Center, who say such ...
... 2 new deaths, may not reflect true reach of the ... the official tally of confirmed U.S. swine flu cases topped ... and Prevention now estimate the true number of infections at ... announced two new deaths linked to the H1N1 virus, bringing ...
... National Fertility Link is Helping Infertile Men and Women Find the ... Resources from Fertility Clinics Through Technology. , ... (PRWEB) ... nation wide resource for couples that are struggling to be pregnant. ...
Cached Medicine News:Health News:New Hope for Walking Normally, Living Better With Cerebral Palsy 2Health News:The future of personalized cancer treatment: An entirely new direction for RNAi delivery 2Health News:18 More Anti-Abortion Activists Arrested at Notre Dame on Saturday; More Arrests Planned for Sunday 2Health News:An Aid to Tailoring Prostate Cancer Treatment 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 3Health News:Swine Flu May Have Infected More Than 100,000 Americans 4Health News:Swine Flu May Have Infected More Than 100,000 Americans 5Health News:Swine Flu May Have Infected More Than 100,000 Americans 6Health News:Swine Flu May Have Infected More Than 100,000 Americans 7Health News:Swine Flu May Have Infected More Than 100,000 Americans 8Health News:Swine Flu May Have Infected More Than 100,000 Americans 9Health News:Swine Flu May Have Infected More Than 100,000 Americans 10Health News:Swine Flu May Have Infected More Than 100,000 Americans 11Health News:Swine Flu May Have Infected More Than 100,000 Americans 12Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 2Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 3
Acuity Astigmatism: Letter Acuity, Astigmatic Clock, Number Acuity, and Tumbling E Tests....
... laboratory analysis that measures a substance produced by ... Annual PSA testing is a safe and effective ... as prostate cancer. One BIOSAFE Collection Kit, ... BIOSAFE's CLIA Certified Laboratory, and review of results ...
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
... from 800 to 40 seconds ... as 2 years of age ... left to right., ,Randot Preschool ... #1: 200 & 100 sec ...
Medicine Products: